Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$358M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$284M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$280M |
| 4 |
NXP Semiconductors
NXPI
|
+$268M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.61B |
| 2 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$407M |
| 3 |
STJ
St Jude Medical
STJ
|
+$368M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$330M |
| 5 |
Apple
AAPL
|
+$302M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.53% |
| 2 | Energy | 3.9% |
| 3 | Technology | 3.29% |
| 4 | Healthcare | 2.41% |
| 5 | Industrials | 2.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DYN
2276
PUT
DELISTED
Dynegy, Inc.
DYN
| $2.36M | ﹤0.01% |
+300,000
| New | +$2.58M |
|
|
JNPR
2277
PUT
DELISTED
Juniper Networks
JNPR
| $2.36M | ﹤0.01% |
84,700
+11,800
| +16% | +$329K |
|
2278
PUT
Sherwin-Williams
SHW
$83.7B
| $2.36M | ﹤0.01% |
22,800
-125,700
| -85% | -$12.7M |
|
2279
PUT
Ally Financial
ALLY
$13.2B
| $2.36M | ﹤0.01% |
115,900
-263,600
| -69% | -$5.6M |
|
|
ESV
2280
CALL
DELISTED
Ensco Rowan plc
ESV
| $2.35M | ﹤0.01% |
65,725
+22,550
| +52% | +$915K |
|
2281
8x8 Inc
EGHT
$262M
| $2.35M | ﹤0.01% |
154,204
+4,802
| +3% | +$72.8K |
|
2282
Neurocrine Biosciences
NBIX
$18.7B
| $2.34M | ﹤0.01% |
54,095
-113,758
| -68% | -$4.87M |
|
2283
Carlyle Group
CG
$16.3B
| $2.34M | ﹤0.01% |
146,778
-305,352
| -68% | -$5.01M |
|
2284
News Corp Class B
NWS
$17.2B
| $2.34M | ﹤0.01% |
173,307
+153,287
| +766% | +$1.98M |
|
|
HZNP
2285
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $2.33M | ﹤0.01% |
158,033
-58,721
| -27% | -$951K |
|
2286
POSCO
PKX
$16.5B
| $2.33M | ﹤0.01% |
36,078
+11,210
| +45% | +$671K |
|
2287
Liberty All-Star Equity Fund
USA
$1.79B
| $2.31M | ﹤0.01% |
423,522
-404,879
| -49% | -$2.19M |
|
|
MNDT
2288
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $2.31M | ﹤0.01% |
183,315
+35,368
| +24% | +$422K |
|
|
OPPE
2289
WisdomTree European Opportunities Fund
OPPE
$291M
| $2.31M | ﹤0.01% |
81,744
+1,800
| +2% | +$48.4K |
|
2290
PUT
Helmerich & Payne
HP
$3.37B
| $2.31M | ﹤0.01% |
34,700
-86,100
| -71% | -$6.13M |
|
2291
Upbound Group
UPBD
$1.17B
| $2.3M | ﹤0.01% |
259,658
+69,496
| +37% | +$632K |
|
|
PIR
2292
DELISTED
Pier 1 Imports, Inc.
PIR
| $2.3M | ﹤0.01% |
16,053
-8,580
| -35% | -$1.26M |
|
2293
Amphenol
APH
$197B
| $2.3M | ﹤0.01% |
129,076
-316,744
| -71% | -$5.48M |
|
2294
Designer Brands
DBI
$314M
| $2.3M | ﹤0.01% |
111,045
-46,529
| -30% | -$965K |
|
|
HSNI
2295
DELISTED
HSN, Inc.
HSNI
| $2.3M | ﹤0.01% |
61,869
-21,169
| -25% | -$758K |
|
2296
CALL
Teradyne
TER
$57.2B
| $2.29M | ﹤0.01% |
73,700
+22,600
| +44% | +$646K |
|
2297
Credit Acceptance
CACC
$5.81B
| $2.28M | ﹤0.01% |
11,453
+2,364
| +26% | +$476K |
|
2298
Alnylam Pharmaceuticals
ALNY
$27.4B
| $2.28M | ﹤0.01% |
44,519
-86,520
| -66% | -$4M |
|
2299
Bread Financial
BFH
$4.47B
| $2.28M | ﹤0.01% |
11,488
-2,140
| -16% | -$405K |
|
2300
CALL
Melco Resorts & Entertainment
MLCO
$2.24B
| $2.28M | ﹤0.01% |
122,900
-386,400
| -76% | -$6.62M |
|
Similar funds
Citigroup's Q1 2017 Portfolio in Review
As of Q1 2017, Citigroup held 7,587 positions worth $112B, up 1.1% from $111B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Citigroup withdrew a net $4.67B in Q1 2017, closing 298 positions and reducing 4,171 holdings. Its most notable exit was St Jude Medical, an estimated $368M position sold in full.
By sector, the portfolio is most concentrated in Financials at 4.5% of assets, down from 5% a quarter earlier, followed by Energy and Technology.
Against the trend, Citigroup opened a new position in Kayne Anderson Acquisition Corp. Unit worth $25.1M.
- Citigroup's largest Q1 2017 buy was Kayne Anderson Acquisition Corp. Unit: 2,500,000 shares worth $25.1M.
- Citigroup added most to Walt Disney in Q1 2017, an estimated $358M increase.
- Citigroup's biggest Q1 2017 reduction was iShares Russell 2000 ETF, cutting an estimated $1.61B.
- Citigroup fully exited St Jude Medical in Q1 2017, selling an estimated $368M.
- Citigroup's ten largest holdings make up 33% of its $112B portfolio in Q1 2017.
- Citigroup opened 332 new positions and closed 298 in Q1 2017.
- Citigroup's portfolio value rose 1.1% quarter-over-quarter to $112B.
Based on Citigroup's 13F filing for Q1 2017, filed 12 May 2017.